Employing newer, faster viral detection technologies is critical to realizing the promise of next generation bioprocessing. Molecular methods such as polymerase chain reaction (PCR) deliver speed and sensitivity, while next generation sequencing (NGS) offers broad detection capabilities and identification of both known and unknown agents.
Our recently introduced Blazar™ rapid molecular platform combines the speed and sensitivity of PCR testing with the broad detection capabilities of NGS and provides biomanufacturers a powerful alternative to traditional in vitro or in vivo virus testing.
- White paper: Rapid Biosafety Testing Enables the Future of Manufacturing
- Service: Blazar™ Rapid Molecular Platform